Revvity to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
Buy this stock as investor China concerns 'are overblown': UBS
May 2, 2025 11:00 PM EDTUBS upgraded Revvity (NYSE: RVTY) to Buy from Neutral in a note this week, arguing that the diagnostics and life sciences company is poised to outperform peers, despite investor concerns about its exposure to China.
We're upgrading Revvity (RVTY) to Buy from Neutral with a view that its growth algorithm could be upside differentiated vs peers', UBS analysts wrote.
The firm cited... More
